Olanzapine Injection, Powder, For Solution
Product Images NDC 39822-1800

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 39822-1800). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xgen Pharmaceuticals Djb, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Olz-label (K5756 01 Label For Olanzapine Injection Usp 10mg 20250723)

Olz-label (K5756 01 Label For Olanzapine Injection Usp 10mg 20250723)
This is a product description for Olanzapine for Injection contained in a single-dose vial with the National Drug Code (NDC) 39822-1800-1. The medication is manufactured by Sandoz Pharmaceutical Ltd, Inc. and is intended for intramuscular use.*
FDA Label Image

Olz-cm (M5756 01 Carton For Olanzapine Injection Usp 10mg 20250722)

Olz-cm (M5756 01 Carton For Olanzapine Injection Usp 10mg 20250722)
This text provides detailed information about a medication with NDC number 39822-1800-1. It is a vial containing 10 mg of olanzapine. The inactive ingredients include lactose monohydrate and tartaric acid. The text advises on dosage instructions, reconstitution details, and administration methods. After reconstitution with 2.1mL of Sterile Water for Injection, each mL will contain 5mg of olanzapine. It is manufactured by UBI Pharma Inc. for XGen Pharmaceuticals DJB, Inc. The text includes storage recommendations both before and after reconstitution. The solution should appear clear and yellow and must be protected from light. This product is indicated for intramuscular use only.*
FDA Label Image

Structure (Olanzapine 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.